Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary NeuroMetrix Reports Successful Marketing Launch of NC-stat(R)|DPNCheck(TM) at the American Diabetes Association 71st Scientific Sessions
NeuroMetrix Reports Successful Marketing Launch of NC-stat(R)|DPNCheck(TM) at the American Diabetes Association 71st Scientific Sessions WALTHAM, Mass., Jul 06, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it met its planned marketing launch date for NC-stat ®
View HTML
Toggle Summary NeuroMetrix To Launch Product Targeted at Diabetes Market at the American Diabetes Association 71st Scientific Sessions
NeuroMetrix To Launch Product Targeted at Diabetes Market at the American Diabetes Association 71st Scientific Sessions WALTHAM, Mass., Jun 20, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it expects to meet its planned launch date for its latest product, NC-stat ®
View HTML
Toggle Summary Nipro Diagnostics and NeuroMetrix Announce Diabetes Focused Collaboration for the Retail Medical Clinic Market
Nipro Diagnostics and NeuroMetrix Announce Diabetes Focused Collaboration for the Retail Medical Clinic Market WALTHAM, Mass. & FT LAUDERDALE, Fla., Jun 15, 2011 (BUSINESS WIRE) -- Nipro Diagnostics, Inc. and NeuroMetrix, Inc. (Nasdaq: NURO) today announced their collaboration to evaluate
View HTML
Toggle Summary NeuroMetrix to Exhibit at The Endocrine Society Annual Meeting "ENDO 2011"
Preview for New Product Targeted at Diabetes Market
View HTML
Toggle Summary NeuroMetrix Reports Q1 2011 Results
NC-stat(R) DPNCheck(TM) Development Progress
View HTML
Toggle Summary NeuroMetrix, Inc. Announces Date for 2011 First Quarter Financial Results Conference Call
NeuroMetrix, Inc. Announces Date for 2011 First Quarter Financial Results Conference Call WALTHAM, Mass., Apr 21, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 first quarter financial results before the opening of the market on April 28, 2011.
View HTML
Toggle Summary NeuroMetrix to Preview New Product Targeted at Diabetes Market at the American Association of Clinical Endocrinologists Annual Meeting
NeuroMetrix to Preview New Product Targeted at Diabetes Market at the American Association of Clinical Endocrinologists Annual Meeting WALTHAM, Mass., Apr 13, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it will preview its newest product - NC-stat ® | DPNCheck
View HTML
Toggle Summary NeuroMetrix Announces Diabetic Neuropathy Scientific Advisory Board
NeuroMetrix Announces Diabetic Neuropathy Scientific Advisory Board WALTHAM, Mass., Mar 21, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it has formed a scientific advisory board of international experts to help guide the scientific, clinical and market development
View HTML
Toggle Summary NeuroMetrix to Present at Canaccord Genuity Musculoskeletal Conference
NeuroMetrix to Present at Canaccord Genuity Musculoskeletal Conference WALTHAM, Mass., Feb 09, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a health care company transforming patient care through neurotechnology, today announced that Shai N.
View HTML
Toggle Summary NeuroMetrix Reports Q4 2010 Financial Results
Strategic Focus on Diabetes; $17M Cash at Year-end 2010
View HTML